There are certain methods of treatment for cancer that have seen little to no improvement in the mortality of cancer patients for at least the past ten years, one of the primary ones being chemo-therapies. There are doctors working tirelessly to finding new treatments that are not only affordable in cost, simple to implement, less invasive to the patient, but also lower the mortality rate of the cancer that is the culprit of the detriment to the health of the patient. The new methods of treatment for this kind of result are those that involve more surgical strikes with more targeted drugs, rather than the way chemo-therapies cause damage indiscriminately in hopes that somehow the cancer will be affected along with the rest of the body.
Dr. Siegall started his endeavor into the science field with gaining his B.S. degree in zoology at the University of Maryland and followed up with obtaining his PhD in genetics at George Washington University. After founding Seattle Genetic, a biotech company head-quartered in Seattle, Washington, he has become one of the leading frontiersmen in the targeting drug industry. Dr. Siegall now has a stout line-up of drugs under his belt with multiple pharmaceutical companies, such as Bayer, Pfizer and etc. With a company that began with humble beginnings, Dr. Siegall is now at the forefront of the industry and leading the way into a more efficient and safer means of treating cancers.
What Dr. Clay Siegall believes to be the reason that he is so successful is his passion to his work. There were times when his company had dire financial situations that could have meant the end of the company but with fierce determination to keep working and focusing in the proper areas to improve, they managed to weather the storm. He equates this thought with the studies done by Francis Galton, who was Charles Darwin’s cousin, in psycho-metrics which concluded that there is not a large difference in intellect among people but rather it is more notable in the work habits of the individuals. That IQ, the schools you attend and the people that you know come second to the passion that you bring to your work.